The Royal Pharmaceutical Society responded to the following consultations in 2021.
RPS response to consultation for original pack dispensing and supply of medicines containing sodium valproate | DHSC
RPS response to Review of temporary provisions in the Human Medicines Regulations 2012 to support influenza and Covid-19 vaccination campaigns | DHSC
Survey completed in response to the proposed Assisted Dying for Terminally Ill Adults (Scotland) Bill
Scottish Government consultation on Suicide Prevention Strategy Development
RPS response to consultation on Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults | NICE
Amending the Road Traffic Act 1988 to allow registered healthcare professionals to complete DVLA medical questionnaires I DVLA
RPS response to GPhC Consultation on changes to requirements for training as a pharmacist independent prescriber
Consultation on a National Care Service for Scotland and associated position statement | Scottish Government
RPS response to consultation on Extending free PPE to the health and care sector
RPS response to survey on CORE20PLUS5 approach to reducing health inequalities | NHSE/I
Covid recovery: public health, services and justice system reforms
NICE Mental Wellbeing at Work Consultation Response | Institute for Apprenticeships and Technical Education
Response to T level outline consultation: Pharmacy Services Specialism | NICE
Royal Pharmaceutical Society response to the consultation on making vaccination a condition of deployment in the health and wider social care sector | DHSC
Joint CPA & RPS Consultation Response Health Education England Global Strategy Refresh 2022-2025 | HEE
Consultation Response to Adult Support & Protection for GP's & Primary Care Teams | Scottish Government
Consultation Response from RPS Wales to HEIW Medicines Administration Units | HEIW Wales
Comment on All Wales Chronic Pain Resources | AWTTC NHS Wales
RPS response to MHRA Point of Care Manufacture Consultation | MHRA
RPS response to consultation on Expanding access to Naloxone | DHSC
NHS 24 Strategic Planning Survey | Scotland
Response to Collective Force for Health and Wellbeing Consultation: Refreshed action plan | COSLA
All Wales COPD Management and Prescribing Guideline | AWTTC NHS Wales
All Adult Wales Asthma Management and Prescribing Guideline��| AWTTC NHS Wales
Scottish Government Digital Health and Care website development survey | DHC Scotland
Consultation on Aligning prescription charges with the State Pension Age | DHSC England
Consultation on the equality, diversity and inclusion strategy | GPhC
Race Equality Action Plan: An Anti-racist Wales | Welsh Gov
NHSX Data Strategy Survey | NHSX
Single Medication Record Survey | NHS Scotland
Consultation on how we set fees for pharmacy professionals | GPhC
Nuromol Dual Action Pain Relief 200mg/500mg tablets (ibuprofen/paracetamol) consultation | MHRA
Regulating healthcare professionals, protecting the public | DHSC
Women's Health Strategy: Call for Evidence | DHSC
Review of Tramadol Resources | AWTTC
Private coronavirus (COVID 19) testing validation | DHSC
Type 1 diabetes in adults: diagnosis and management (update) | NICE
Indicators for antidepressant prescribing and dementia | NICE
Consultation on a Patient Safety Commissioner Role for Scotland | Scottish Government
National Healthcare Uniform Workforce Consultation | NHS Supply Chain
Prescription medicine dependence and withdrawal | Scottish Government
Draft Environmental Protection (single use plastic products) regulations | Scottish Government
Reviewing our process for health technology evaluation | NICE
Guideline on weight management | NICE
Call for Evidence – Barriers to research for controlled drugs (excluding synthetic cannabinoids) | ACMD
Hana 75 microgram film-coated tablets (Desogestrel): Public Consultation | MHRA
Lovima 75 microgram film-coated tablets (Desogestrel): Public Consultation | MHRA
Strategy Consultation | CQC
Community Diagnostics | Welsh Government
Draft design principles – clinical and care professional leadership in Integrated Care Systems (ICSs) | NHS Confederation
Inquiry into the Covid-19 outbreak on health and social care in Wales: Post-Covid Syndrome | Welsh Parliament Health, Social Care and Sport Committee
White Paper on health and social care | House of Commons Health and Social Care Committee Department
NHS Provider Selection regime: Consultation on proposals | NHS
Shared Decision Making | NICE
Transformation of Urgent and Emergency Care | NHS
Clostridioides difficile infection: antimicrobial prescribing - guideline consultation | NICE
Initial Clinical Management of Adult Smokers in Secondary Care | AWTTC
Guidance for the Provision of Anaesthetic Services for the Perioperative Care of Elective and Urgent Care Patients Consultation | RCoA
Termination of Pregnancy arrangements in Wales | Welsh Government
Home use of both pills for early medical abortion | DHSC
Consultation on Future Arrangements for Early Medical Abortion at Home | Scottish Government
Workplace health: long-term sickness absence and capability to work | NICE
Your views: building a strong, integrated care system across England | NHS England
Managing concerns about pharmacy professionals: Our strategy for change | GPhC